/ Lesley Ogilvie

INDO-GERMAN AMR Workshop – CARPE DIEM

INDO-GERMAN AMR Workshop – “Challenging Antibiotic Resistance: Perspectives on Novel Tools and Diagnostics for Efficient Management”, co-hosted by Manipal University and the Global AMR R&D Hub, funded by the Indo-German Science & Technology Centre (IGSTC) in Berlin from the 16.-17. May 2022. Read more here:

Press Release – German Network against Antimicrobial Resistance (May 2022)

13.05.2022: The German Network against Antimicrobial Resistance (Deutsches Netzwerk gegen Antimikrobielle Resistenzen – DNAMR), which the Global AMR R&D Hub is a member of, just published a press release underlining the importance of a collaborative approach between research, development and the private sector when addressing AMR. Read more here.

New Vacancy – Head of the Global AMR R&D Hub Secretariat (m/w/d) – Berlin

29.04.2021: Job posting for the Head of the Global AMR R&D Hub Secretariat (m/f/d). An exciting opportunity to be part of the Global AMR R&D Hub team in Berlin!

Apply by the 26th May 2022.

Find out more here:

 

Launch of the Cross-sector report on One Health

05.04.2022: Our Dynamic Dashboard continues to expand with the launch of the Cross-Sector Report on One Health! In April 2021, the Dynamic Dashboard became truly One Health with the inclusion of animal and environmental health projects. Access the full report here

Newsletter March 2022

04.04.2022: Read about the Hub’s recent activities including the launch of Cross-sector report in our March Newletter. Access the Newsletter here:

End of year Newsletter out now!

20.12.2021: Read about the Hub’s activities over the year including our annual analysis of the Dynamic Dashboard data, partnerships and AMR advocacy. Access the Newsletter here:

G7 Finance Ministers’ Statement on Actions to Support Antibiotic Development

 

13.12.2021  G7 Finance Ministers met on the 13th December to agree on a statement of actions to support antibiotic development, highlighting the continued commitment of the G7 member states to solving the challenges facing the development of and access to the most needed existing and new antibiotics.

The Global AMR R&D Hub is honoured to be able to contribute, alongside the World Health Organisation (WHO), to the monitoring of development within the space, with a commitment to prepare a progress update for G7 Finance and Health Ministers in 2022. We look forward to taking on this challenge and seeing barriers being broken down that are currently hindering the preservation of and access to existing antibiotics, as well as the development of priority antibiotics, in tandem with a strengthening of the R&D landscape for antibiotic development.

Access the Policy Statement & annexes here.

Annual Report 2021 – now available!

09.11.2021 We have just published our ‘Annual Report 2021: The Global AMR R&D Funding Landscape’. The report provides a global snapshot of the AMR R&D activities across the full One Health spectrum, offering an evidence base to foster global priority setting and decision making on the allocation of resources. Access the full report here

Global Health Policy & Strategy Program Officer (m/f/d) – Berlin

07.12.2021: New job posting for a Global Health Policy & Strategy Program Officer. A great opportunity to be part of the Global AMR R&D Hub team in Berlin!

Apply by the 2nd January 2022.

Link to further details here:

Animal health R&D in LMICs

23.11.2021:  Antimicrobial resistance is a global public health threat that disproportionately affects low- and middle-income countries (LMICs). It presents risks to human health and also has severe implications for the health and welfare of animal populations, with major food security and environmental implications. IDRC and the Global AMR R&D Hub are pleased to publish a new report, which analyses the funding patterns of animal health AMR R&D in LMICs. In publishing this report, our two organizations hope to provide insight into investment and data gaps to inform the international community and provide evidence to help set future funding priorities in AMR research.

Link to report here.

Link to IDRC perspective piece: https://www.idrc.ca/en/perspectives/animal-AMR-funding-gaps